Thyroid Cancer Trial, Recruiting NCT07370675 Sponsor: Christian Grønhøj Larsen Condition: Thyroid Cancer
Back to Thyroid Cancer

Thyroid Cancer Trial, Recruiting

NCT07370675
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 30 years of age or older
  • You have a single thyroid nodule that was found to be a "follicular neoplasm" or "suspicious for a follicular neoplasm" based on a biopsy result (this is called a Category IV result in a standard classification system used by doctors)
  • The nodule is smaller than 2 cm in all directions (roughly smaller than a grape)
  • Your thyroid ultrasound scan result falls into a category called EU-TIRADS 3 or 4, which generally means the nodule looks low to moderately suspicious (confirm with trial site)

Who may not be able to join:

  • Your thyroid ultrasound result falls into the EU-TIRADS 5 category, meaning the nodule looks more highly suspicious (confirm with trial site)
  • There are signs that the disease may have spread — for example, suspicious lymph nodes seen on a PET scan, ultrasound, or CT scan, or signs that the tumor is growing outside its normal boundary or has an irregular shape
  • The nodule is located in a risky position near important structures such as blood vessels, a nerve near the voice box, or the windpipe
  • You have had thyroid surgery before
  • You have a condition called hyperparathyroidism, where certain blood calcium and hormone levels are above specific limits (confirm with trial site)
  • You are currently pregnant
  • You are not able to give your own consent to take part in the trial
  • A hormone called calcitonin is above the normal range in your blood test results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0045 45356863

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Christian Grønhøj Larsen
Registry
ClinicalTrials.gov
Start date
16 January 2026
Est. completion
16 January 2033

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Number of participants who undergo surgical intervention or experience disease progression during active surveillance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov